vTv Therapeutics Inc. (VTVT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, vTv Therapeutics Inc. reported revenue of $0, down 100.0% from the prior year. The company ran a net loss. It held $89.90M in total assets against $25.46M in total liabilities.
Key ratios (FY2025)
-41.9%
Return on equity
-100.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1.02M | $0 | $2.02M | $4.00M | $6.41M | $2.76M | $12.43M | $291.0K | $634.0K |
| Operating Income | -$32.81M | -$24.18M | -$25.50M | -$22.54M | -$21.66M | -$11.85M | -$20.89M | -$19.82M | -$50.68M | -$55.02M |
| Net Income | -$26.97M | -$18.46M | -$20.25M | -$19.16M | -$12.99M | -$8.50M | -$13.04M | -$7.91M | -$16.14M | -$16.35M |
| Total Assets | $89.90M | $38.27M | $11.02M | $33.24M | $25.47M | $14.79M | $9.27M | $8.56M | $27.92M | $54.49M |
| Total Liabilities | $25.46M | $23.96M | $29.57M | $27.40M | $10.25M | $11.00M | $18.11M | $28.93M | $47.52M | $22.93M |
| Shareholders' Equity | $64.44M | $12.20M | -$24.68M | -$10.74M | -$9.74M | -$80.10M | -$49.02M | -$82.85M | -$151.05M | -$90.94M |
| Cash & Equivalents | $88.93M | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $1.78M | $1.68M | $11.76M | $51.51M |
| Operating Cash Flow | -$25.25M | -$25.31M | -$19.08M | -$16.02M | -$19.31M | -$18.00M | -$23.02M | -$26.86M | -$44.56M | -$48.21M |
| Capital Expenditures | — | $0 | $0 | $21.0K | $0 | $0 | $70.0K | $5.0K | $57.0K | $87.0K |